Resources

Type of publications
Regions
Diseases

5192 results found

2021 ∙ Desalermos, A. Pimienta, M. Kalligeros, M. Shehadeh, F. Diamantopoulos, L. Karamanolis, G. Caldera, F. Farraye, F. A.

Safety of Immunizations for the Adult Patient With Inflammatory Bowel Disease-A Systematic Review and Meta-analysis

  • Adults
  • Hepatitis B
  • Influenza
  • Herpes zoster
  • Pneumococcal disease
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Juvet, L. K. Robertson, A. H. Laake, I. Mjaaland, S. Trogstad, L.

Safety of Influenza A H1N1pdm09 Vaccines: An Overview of Systematic Reviews

  • All age groups
  • Influenza
  • Safety
Methodological quality (AMSTAR 2):
Not applicable
2021 ∙ Bandell, A. Ambrose, C. S. Maniaci, J. Wojtczak, H.

Safety of live attenuated influenza vaccine (LAIV) in children and adults with asthma: a systematic literature review and narrative synthesis

  • Children
  • Adolescents
  • Adults
  • Influenza
  • Safety
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Chen, M. Yuan, Y. Zhou, Y. Deng, Z. Zhao, J. Feng, F. Zou, H. Sun, C.

Safety of SARS-CoV-2 vaccines: a systematic review and meta-analysis of randomized controlled trials

  • Adolescents
  • Adults
  • Older adults
  • COVID-19
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Lv, M. Luo, X. Shen, Q. Lei, R. Liu, X. Liu, E. Li, Q. Chen, Y.

Safety, immunogenicity, and efficacy of COVID-19 vaccines in children and adolescents: A systematic review

  • Children
  • Adolescents
  • COVID-19
  • Safety
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Rogliani, P. Chetta, A. Cazzola, M. Calzetta, L.

SARS-CoV-2 Neutralizing Antibodies: A Network Meta-Analysis across Vaccines

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Sung, K. Y. Chang, T. E. Wang, Y. P. Lin, C. C. Chang, C. Y. Hou, M. C. Lu, C. L.

SARS-CoV-2 vaccination in patients with inflammatory bowel disease: systemic review and meta-analysis

  • Adolescents
  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Abid, M. A. Abid, M. B.

SARS-CoV-2 vaccine response in CAR T-cell therapy recipients: A systematic review and preliminary observations

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Sakuraba, Atsushi Luna, Alexander Micic, Dejan

Serologic response to coronavirus disease 2019 (COVID-19) vaccination in patients with immune-mediated inflammatory diseases: a systematic review and meta-analysis

  • Adults
  • Older adults
  • Healthcare workers
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Aldakak, L. Huber, V. M. Ruhli, F. Bender, N.

Sex difference in the immunogenicity of the quadrivalent Human Papilloma Virus vaccine: Systematic review and meta-analysis

  • Adolescents
  • Adults
  • Human papillomavirus (HPV)
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
Loading...